Santen facts and figures
€1.9 billion revenue
(approx. 249.6 billion yen)
94% of revenue from prescription ophthalmic pharmaceuticals
Sales outside Japan account for 32% of corporate revenue
4,229 employees globally
Products supplied in over 60 countries
Dedicated facilities for ongoing research and development: Nara (Japan), Evry (France), Emeryville (US)
Three manufacturing sites: Noto and Shiga (Japan), Suzhou (China)
Source: Santen Pharmaceutical Co., Ltd. Fiscal year (FY2020) ended 31 March 2021.
